{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:47:54Z","timestamp":1793724474440,"version":"4.6.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Health Fund \u2013 Brazilian Ministry of Health","award":["123\/2020"],"award-info":[{"award-number":["123\/2020"]}],"id":[{"id":"https:\/\/ror.org\/02y7p0749","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Health Fund \u2013 Brazilian Ministry of Health","award":["123\/2020"],"award-info":[{"award-number":["123\/2020"]}],"id":[{"id":"https:\/\/ror.org\/02y7p0749","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09937-2","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T04:01:37Z","timestamp":1727755297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Role of histopathological, serological and molecular findings for the early diagnosis of treatment failure in leprosy"],"prefix":"10.1186","volume":"24","author":[{"given":"Bruno","family":"de Carvalho Dornelas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willian Vargas Ten\u00f3rio","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Pablo Ferraz","family":"de Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Salom\u00e3o","family":"Daud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe dos Anjos Rodrigues","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deiriene Rodrigues","family":"de Oliveira Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Eul\u00e1lio","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facio Borges","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo Fernandes","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleverson Teixeira","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Maria Bernardes","family":"Goulart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"9937_CR1","unstructured":"Vogelsang ThM. Gerhard Henrik Armauer Hansen 1841\u20131912. The discoverer of the leprosy bacillus. His life and his work. Int J Lepr Other Mycobact Dis [Internet]. 1978;46(3\u20134):257\u2013332. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/365786"},{"key":"9937_CR2","unstructured":"World Health Organization. Situation de la l\u00e8pre (maladie de Hansen) dans le monde, 2021: vers l\u2019interruption de la transmission [Internet]. 2021. https:\/\/population.un.org\/wpp\/Download\/Standard\/Population\/."},{"key":"9937_CR3","doi-asserted-by":"crossref","unstructured":"Goulart IMB, Penna GO, Cunha G. Imunopatologia da hansen\u00edase: a complexidade dos mecanismos da resposta imune do hospedeiro ao Mycobacterium leprae. Rev Soc Bras Med Trop [Internet]. 2002;35(4):363\u201375. http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822002000400014&lng=pt&tlng=pt","DOI":"10.1590\/S0037-86822002000400014"},{"key":"9937_CR4","unstructured":"Soares CT. Histopathological Diagnosis of Leprosy [Internet]. 1st ed. BENTHAM SCIENCE PUBLISHERS; 2021. 180\u2013221 p. https:\/\/www.eurekaselect.com\/193161\/volume\/1"},{"key":"9937_CR5","unstructured":"Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis [Internet]. 1966;34(3):255\u201373. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/5950347"},{"key":"9937_CR6","unstructured":"World Health Organization Study Group. Chemotherapy of leprosy for control programs. WHO\u2013Technical Report Series. 1982;675:1\u201333."},{"key":"9937_CR7","unstructured":"World Health Organization. Chemotherapy of leprosy: report of a WHO study group [meeting held in Geneva from 1 to 5 November 1993 [Internet]. Geneva. 1994 [cited 2023 Oct 7]. https:\/\/iris.who.int\/handle\/10665\/39877"},{"key":"9937_CR8","doi-asserted-by":"crossref","unstructured":"Gelber RH, Grosset J. The chemotherapy of leprosy: an interpretive history Leprosy Review. J Subscr Inform for. Vol. 83. 2012.","DOI":"10.47276\/lr.83.3.221"},{"key":"9937_CR9","unstructured":"World Health Organization. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy [Internet]. 2018 [cited 2023 Oct 7]. https:\/\/www.jstor.org\/stable\/pdf\/resrep30119.1.pdf"},{"key":"9937_CR10","doi-asserted-by":"publisher","unstructured":"Pardillo FEF, Fajardo TT, Abalos RM, Scollard D, Gelber RH. Methods for the Classification of Leprosy for Treatment Purposes. Clinical Infectious Diseases [Internet]. 2007;44(8):1096\u20139. https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/https:\/\/doi.org\/10.1086\/512809","DOI":"10.1086\/512809"},{"key":"9937_CR11","doi-asserted-by":"crossref","unstructured":"Kumar B, Dogra S, Leprosy. A disease with diagnostic and management challenges! Indian J Dermatol Venereol Leprol [Internet]. 2009;75(2):111. http:\/\/www.ijdvl.com\/text.asp?2009\/75\/2\/111\/48653","DOI":"10.4103\/0378-6323.48653"},{"key":"9937_CR12","doi-asserted-by":"crossref","unstructured":"Scollard DM. Classification of Leprosy: A Full Color Spectrum, or Black and White? International Journal of Leprosy and Other Mycobacterial Diseases [Internet]. 2004;72(2):166. http:\/\/lepr.allenpress.com\/lepronline\/?request=get-abstract&doi=10.1489\/1544-581X(2004)072<0166:COLAFC>2.0.CO;2","DOI":"10.1489\/1544-581X(2004)072<0166:COLAFC>2.0.CO;2"},{"key":"9937_CR13","doi-asserted-by":"crossref","unstructured":"Teixeira AC, Cruvinel DL, de Roma FR, Luppino LF, Resende LHP, de Sousa T et al. Avalia\u00e7\u00e3o da concord\u00e2ncia entre exames cl\u00ednicos e laboratoriais no diagn\u00f3stico da hansen\u00edase. Rev Soc Bras Med Trop [Internet]. 2008;41(suppl 2):48\u201355. http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822008000700011&lng=pt&tlng=pt","DOI":"10.1590\/S0037-86822008000700011"},{"key":"9937_CR14","doi-asserted-by":"publisher","unstructured":"Parkash O. Classification of leprosy into multibacillary and paucibacillary groups: an analysis. FEMS Immunol Med Microbiol [Internet]. 2009;55(1):1\u20135. https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/https:\/\/doi.org\/10.1111\/j.1574-695X.2008.00491.x","DOI":"10.1111\/j.1574-695X.2008.00491.x"},{"key":"9937_CR15","doi-asserted-by":"crossref","unstructured":"Rajan L, Das M, Ponnaiya J, Ebenezer M. Clinical profile of Relapse in Leprosy and Laboratory Correlation, including Mouse footpad inoculation and Molecular tests, in a Tertiary Leprosy Institution. Lepr Rev [Internet]. 2021;92(3):260\u20138. https:\/\/leprosyreview.org\/article\/92\/3\/20-21026","DOI":"10.47276\/lr.92.3.260"},{"key":"9937_CR16","unstructured":"Minist\u00e9rio da Sa\u00fade. Nota informativa no 51 [Internet]. Coordena\u00e7\u00e3o-Geral de Hansen\u00edase e Doen\u00e7as em Elimina\u00e7\u00e3o. CGHDE\/DEVIT\/SVS\/MS. 2015; 2015 [cited 2023 Mar 18]. https:\/\/www.saude.pr.gov.br\/sites\/default\/arquivos_restritos\/files\/documento\/2020-04\/notainformativa51recidivaresisteinsuficienciamedicamentosanahanseniase.pdf"},{"key":"9937_CR17","doi-asserted-by":"crossref","unstructured":"Lazo-Porras M, Prutsky GJ, Barrionuevo P, Tapia JC, Ugarte-Gil C, Ponce OJ, et al. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis. BMC Infectious Diseases. Volume 20. BioMed Central Ltd.; 2020.","DOI":"10.1186\/s12879-019-4665-0"},{"key":"9937_CR18","unstructured":"Levy L. Treatment failure in leprosy. Int J Lepr Other Mycobact Dis [Internet]. 1976;44(1\u20132):177\u201382. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/776854"},{"key":"9937_CR19","doi-asserted-by":"crossref","unstructured":"Guerrero-Guerrero MI, Muvdi-Arenas S, Le\u00f3n-Franco CI. Relapses in multibacillary leprosy patients: a retrospective cohort of 11 years in Colombia. Lepr Rev [Internet]. 2012;83(3):247\u201360. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23356026","DOI":"10.47276\/lr.83.3.247"},{"key":"9937_CR20","doi-asserted-by":"crossref","unstructured":"Nascimento ACMdo, dos Santos DF, Antunes DE, Gon\u00e7alves MA, Santana MA, de O, Dornelas B et al. C,. Leprosy Relapse: A Retrospective Study on Epidemiologic, Clinical, and Therapeutic Aspects at a Brazilian Referral Center. International Journal of Infectious Diseases [Internet]. 2022;118:44\u201351. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222000108","DOI":"10.1016\/j.ijid.2022.01.009"},{"key":"9937_CR21","doi-asserted-by":"crossref","unstructured":"Thappa D, Kaimal S. Relapse in leprosy. Indian J Dermatol Venereol Leprol [Internet]. 2009;75(2):126. http:\/\/www.ijdvl.com\/text.asp?2009\/75\/2\/126\/48656","DOI":"10.4103\/0378-6323.48656"},{"issue":"1","key":"9937_CR22","first-page":"9","volume":"36","author":"PS Rosa","year":"2011","unstructured":"Rosa PS. Relapse associated with drug resistance in leprosy. Hansen Int. 2011;36(1):9\u201310.","journal-title":"Hansen Int"},{"key":"9937_CR23","unstructured":"World. Health Organization. A guide for surveillance of antimicrobial resistance in leprosy 2017 update. 2017."},{"key":"9937_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jgar.2023.10.006","volume":"35","author":"S Chhabra","year":"2023","unstructured":"Chhabra S, Narang T, Sahu S, Sharma K, Shilpa S, Sharma A, et al. High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: an indication to revisit second line anti-leprosy treatment regimen. J Glob Antimicrob Resist. 2023;35:262\u20137.","journal-title":"J Glob Antimicrob Resist"},{"issue":"6","key":"9937_CR25","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.4269\/ajtmh.23-0084","volume":"109","author":"M Patial","year":"2023","unstructured":"Patial M, Hanumanthu V, Chhabra S, Singh I, Chatterjee D, Narang T, et al. Assessment of Clinical, histopathological, and bacteriological findings in treated Leprosy patients with persistent skin lesions: a retrospective cohort study. Am J Trop Med Hyg. 2023;109(6):1260\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"9937_CR26","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.cmi.2018.02.022","volume":"24","author":"E Cambau","year":"2018","unstructured":"Cambau E, Saunderson P, Matsuoka M, Cole ST, Kai M, Suffys P, et al. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009\u201315. Clin Microbiol Infect. 2018;24(12):1305\u201310.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"9937_CR27","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1093\/cid\/ciz570","volume":"70","author":"PS Rosa","year":"2020","unstructured":"Rosa PS, D\u2019Espindula HRS, Melo ACL, Fontes ANB, Finardi AJ, Belone AFF, et al. Emergence and transmission of drug-\/multidrug-resistant mycobacterium leprae in a former leprosy colony in the Brazilian amazon. Clin Infect Dis. 2020;70(10):2054\u201361.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"9937_CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.47878\/hi.2009.v34.35162","volume":"34","author":"SM Di\u00f3rio","year":"2009","unstructured":"Di\u00f3rio SM, Rosa PS, Belone AFF, Sartori BGC, Trino LM, Baptista IMFD, et al. Relapse related to drug resistance in leprosy. Hansen Int. 2009;34(1):43\u20138.","journal-title":"Hansen Int"},{"key":"9937_CR29","doi-asserted-by":"crossref","unstructured":"Aubry A, Sammarco Rosa P, Chauffour A, Fletcher ML, Cambau E, Avanzi C. Drug resistance in leprosy: an update following 70 years of chemotherapy. Infectious Diseases Now. Volume 52. Elsevier Masson s.r.l.; 2022. pp. 243\u201351.","DOI":"10.1016\/j.idnow.2022.04.001"},{"key":"9937_CR30","unstructured":"World Health Organization. Towards zero leprosy. Global leprosy (Hansen\u2019s Disease) strategy 2021\u20132030 [Internet]. Organiza\u00e7\u00e3o Mundial da Sa\u00fade. 2021. http:\/\/apps.who.int\/bookorders"},{"key":"9937_CR31","doi-asserted-by":"crossref","unstructured":"Lockwood DNJ, Butlin CR, Penna GO. Current leprosy multi-drug treatment duration for mb patients (12 months) produces good clinical outcomes over many years. Leprosy Review. Volume 92. Lepra; 2021. pp. 97\u2013101.","DOI":"10.47276\/lr.92.2.97"},{"key":"9937_CR32","doi-asserted-by":"crossref","unstructured":"Torrella A, Solis R, Perez E, Medina Y, Kerguelen C, Olaya P, Anti M. leprae IgM antibody determination by ultramicroimmunoenzymatic (UMELISA HANSEN) for the diagnosis and monitoring leprosy. Rev Inst Med Trop Sao Paulo [Internet]. 1998;40(3):177\u201382. http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46651998000300008&lng=en&tlng=en","DOI":"10.1590\/S0036-46651998000300008"},{"issue":"4","key":"9937_CR33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.13181\/mji.v28i4.2643","volume":"28","author":"A Devita","year":"2019","unstructured":"Devita A, Ibrahim F, Menaldi SLSW, Budianti A, Yasmon A. Detection of mycobacterium leprae using real-time PCR in paucibacillary leprosy patients with negative acid-fast bacilli smears. Med J Indonesia. 2019;28(4):351\u20137.","journal-title":"Med J Indonesia"},{"key":"9937_CR34","unstructured":"Minist\u00e9rio da Sa\u00fade. Guia de procedimentos t\u00e9cnicos: baciloscopia em hansen\u00edase [Internet]. 1st ed. Editora MS. 2010; 2010 [cited 2023 Oct 7]. 51 p. https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/guia_procedimentos_tecnicos_corticosteroides_hanseniase.pdf"},{"key":"9937_CR35","doi-asserted-by":"publisher","unstructured":"Massone C. Histopathology of the Skin. In: Leprosy [Internet]. Milano: Springer Milan; 2012. pp. 115\u201336. http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-88-470-2376-5_12","DOI":"10.1007\/978-88-470-2376-5_12"},{"key":"9937_CR36","unstructured":"Ridley DS, Hilson GR. A logarithmic index of bacilli in biopsies. I. Method. Int J Lepr Other Mycobact Dis [Internet]. 1967;35(2):184\u20136. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/5338960"},{"key":"9937_CR37","doi-asserted-by":"crossref","unstructured":"Lobato J, Costa MP, De Melo Reis \u00c9, Gon\u00e7alves MA, Spencer JS, Brennan PJ et al. Comparison of three immunological tests for leprosy diagnosis and detection of subclinical infection. Lepr Rev [Internet]. 2011;82(4):389\u2013401. Available from: https:\/\/leprosyreview.org\/article\/82\/4\/38-9401.","DOI":"10.47276\/lr.82.4.389"},{"key":"9937_CR38","doi-asserted-by":"publisher","unstructured":"Araujo S, Freitas LO, Goulart LR, Goulart IMB. Molecular Evidence for the Aerial Route of Infection of Mycobacterium leprae and the Role of Asymptomatic Carriers in the Persistence of Leprosy. Clinical Infectious Diseases [Internet]. 2016;63(11):1412\u201320. https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/https:\/\/doi.org\/10.1093\/cid\/ciw570","DOI":"10.1093\/cid\/ciw570"},{"key":"9937_CR39","doi-asserted-by":"publisher","unstructured":"Truman RW, Andrews PK, Robbins NY, Adams LB, Krahenbuhl JL, Gillis TP. Enumeration of Mycobacterium leprae Using Real-Time PCR. Small PLC, editor. PLoS Negl Trop Dis [Internet]. 2008;2(11):e328. https:\/\/doi.org\/10.1371\/journal.pntd.0000328","DOI":"10.1371\/journal.pntd.0000328"},{"key":"9937_CR40","doi-asserted-by":"crossref","unstructured":"Agresti A. An Introduction to Categorical Data Analysis [Internet]. Second. Wiley; 2007. 400 p. (Wiley Series in Probability and Statistics). https:\/\/onlinelibrary.wiley.com\/doi\/book\/10.1002\/0470114754","DOI":"10.1002\/0470114754"},{"key":"9937_CR41","doi-asserted-by":"crossref","unstructured":"Hosmer DW, Lemeshow S, Sturdivant RX. Applied Logistic Regression [Internet]. Second. Wiley; 2013. 392 p. (Wiley Series in Probability and Statistics). https:\/\/onlinelibrary.wiley.com\/doi\/book\/10.1002\/9781118548387","DOI":"10.1002\/9781118548387"},{"key":"9937_CR42","doi-asserted-by":"crossref","unstructured":"Narang T, Bishnoi A, Thakur V, Chatterjee D, Razmi TM, Kamat D et al. Persistent plaques after release from treatment in slit-skin smear negative leprosy patients: wait and watch or adopt a proactive approach? Dermatol Ther. 2020;33(6).","DOI":"10.1111\/dth.14226"},{"key":"9937_CR43","doi-asserted-by":"crossref","unstructured":"Tiago LM, de Dos Santos P, Antunes DF, Tiago DE, Goulart LMP. IMB. Assessment of neuropathic pain in leprosy patients with relapse or treatment failure by infrared thermography: a cross-sectional study. PLoS Negl Trop Dis. 2021;15(9).","DOI":"10.1371\/journal.pntd.0009794"},{"issue":"1","key":"9937_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4269\/ajtmh.18-0256","volume":"100","author":"T Narang","year":"2019","unstructured":"Narang T, Bishnoi A, Dogra S, Saikia UN. Kavita. Alternate anti-leprosy regimen for multidrug therapy refractory leprosy: a retrospective study from a Tertiary Care Center in North India. Am J Trop Med Hyg. 2019;100(1):24\u201330.","journal-title":"Am J Trop Med Hyg"},{"key":"9937_CR45","doi-asserted-by":"publisher","unstructured":"Lobo D. Treatment failures with multidrug therapy. Lepr Rev [Internet]. 1992;63. http:\/\/www.gnresearch.org\/doi\/https:\/\/doi.org\/10.5935\/0305-7518.19920060","DOI":"10.5935\/0305-7518.19920060"},{"key":"9937_CR46","doi-asserted-by":"crossref","unstructured":"Singh A, Weng X, Nath I. Skin Biopsy in Leprosy. In: Skin Biopsy - Perspectives [Internet]. InTech; 2011. http:\/\/www.intechopen.com\/books\/skin-biopsy-perspectives\/skin-biopsy-in-leprosy","DOI":"10.5772\/22227"},{"issue":"1","key":"9937_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4155\/cli.13.121","volume":"4","author":"MLF Penna","year":"2014","unstructured":"Penna MLF. Considerations in the design of clinical trials for multibacillary leprosy treatment. Clin Investig (Lond). 2014;4(1):77\u201386.","journal-title":"Clin Investig (Lond)"},{"key":"9937_CR48","doi-asserted-by":"publisher","unstructured":"Nery JAC, Sales AM, Hacker MAVB, Moraes MO, Maia RC, Sarno EN et al. Low rate of relapse after twelve-dose multidrug therapy for hansen\u2019s disease: A 20-year cohort study in a brazilian reference center. Van Weyenbergh J, editor. PLoS Negl Trop Dis [Internet]. 2021;15(5):e0009382. https:\/\/doi.org\/10.1371\/journal.pntd.0009382","DOI":"10.1371\/journal.pntd.0009382"},{"issue":"1","key":"9937_CR49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/0019-5154.147791","volume":"60","author":"SM Kumaran","year":"2015","unstructured":"Kumaran SM, Bhat IP, Madhukara J, Rout P, Elizabeth J. Comparison of bacillary index on slit skin smear with bacillary index of granuloma in leprosy and its relevance to present therapeutic regimens. Indian J Dermatol. 2015;60(1):51\u20134.","journal-title":"Indian J Dermatol"},{"issue":"2","key":"9937_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4103\/ijmy.ijmy_7_20","volume":"9","author":"A Ansari","year":"2020","unstructured":"Ansari A, Saxena K, Singh K, Choudhary A, Singh A, Tripathi A, et al. Clinicobacteriological evaluation of leprosy patients with 1\u20135 skin lesions. Int J Mycobacteriol. 2020;9(2):209\u201311.","journal-title":"Int J Mycobacteriol"},{"issue":"1","key":"9937_CR51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.30699\/ijp.2021.534122.2682","volume":"17","author":"SM Naik","year":"2022","unstructured":"Naik SM, More SA, Joshi SR. Correlation of histomorphological findings with bacteriological index in Leprosy patients. Iran J Pathol. 2022;17(1):48\u201355.","journal-title":"Iran J Pathol"},{"key":"9937_CR52","doi-asserted-by":"crossref","unstructured":"Thappa D, Malathi M. Fixed-duration therapy in leprosy: Limitations and opportunities. Indian J Dermatol [Internet]. 2013;58(2):93. http:\/\/www.e-ijd.org\/text.asp?2013\/58\/2\/93\/108029","DOI":"10.4103\/0019-5154.108029"},{"key":"9937_CR53","doi-asserted-by":"crossref","unstructured":"Sharma A, Sharma V, Rajwanhi A, Das A, Kaur I, Kumar B. Presence of M. Leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR. Lepr Rev. 1999;70(3).","DOI":"10.5935\/0305-7518.19990031"},{"key":"9937_CR54","doi-asserted-by":"crossref","unstructured":"Gelber RH, Balagon VF, Cellona RV. The Relapse Rate in MB Leprosy Patients Treated with 2-Years of WHO-MDT is Not Low. International Journal of Leprosy and Other Mycobacterial Diseases [Internet]. 2004;72(4):493. http:\/\/lepr.allenpress.com\/lepronline\/?request=get-abstract&doi=10.1489\/1544-581X(2004)72<493:TRRIML>2.0.CO;2","DOI":"10.1489\/1544-581X(2004)72<493:TRRIML>2.0.CO;2"},{"issue":"2","key":"9937_CR55","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4269\/ajtmh.2009.81.330","volume":"81","author":"TT Fajardo","year":"2009","unstructured":"Fajardo TT, Villahermosa L, Pardillo FEF, Abalos RM, Burgos J, Dela Cruz E, et al. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens. Am J Trop Med Hyg. 2009;81(2):330\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"9937_CR56","doi-asserted-by":"crossref","unstructured":"Premalatha P, Renuka I, Meghana A, Devi S, Charyulu P, Sampoorna G. Utility of bacillary index in slit skin smears in correlation with clinical and histopathological alterations in hansen\u2019s disease: An attempt to revive a simple useful procedure. Ann Med Health Sci Res [Internet]. 2016;6(3):181. http:\/\/www.amhsr.org\/text.asp?2016\/6\/3\/181\/183936","DOI":"10.4103\/2141-9248.183936"},{"key":"9937_CR57","doi-asserted-by":"crossref","unstructured":"Suri Sushilkumar K, Iyer Rekha R, Patel Darshana U, Supriya B. Baxi Seema. Histopathology and Clinico-histopathological correlation in Hansen\u2019s disease. J Res Med Dent Sci [Internet]. 2014;2(1):37. http:\/\/www.scopemed.org\/fulltextpdf.php?mno=156825","DOI":"10.5455\/jrmds.2014217"},{"key":"9937_CR58","doi-asserted-by":"crossref","unstructured":"de Macedo CS, Lara FA, Pinheiro RO, Schmitz V, de Berr\u00eado-Pinho M, Pereira GM et al. New insights into the pathogenesis of leprosy: contribution of subversion of host cell metabolism to bacterial persistence, disease progression, and transmission. F1000Res [Internet]. 2020;9:70. https:\/\/f1000research.com\/articles\/9-70\/v1","DOI":"10.12688\/f1000research.21383.1"},{"key":"9937_CR59","doi-asserted-by":"crossref","unstructured":"Berto da Silva Prata R, Garcia de Mattos Barbosa M, Jorge de Andrade Silva B. Araujo da Paix\u00e3o de Oliveira J, Lameira Bittencourt T, Olmo Pinheiro R. Macrophages in the Pathogenesis of Leprosy. In: Macrophage Activation - Biology and Disease. IntechOpen; 2020.","DOI":"10.5772\/intechopen.88754"},{"key":"9937_CR60","doi-asserted-by":"publisher","unstructured":"Mattos KA, Oliveira VCG, Berr\u00eado-Pinho M, Amaral JJ, Antunes LCM, Melo RCN et al. Mycobacterium leprae intracellular survival relies on cholesterol accumulation in infected macrophages: a potential target for new drugs for leprosy treatment. Cell Microbiol [Internet]. 2014;16(6):797\u2013815. https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/cmi.12279","DOI":"10.1111\/cmi.12279"},{"key":"9937_CR61","doi-asserted-by":"crossref","unstructured":"Cabral N, de Figueiredo V, Gandini M, de Souza CF, Medeiros RA, Lery LMS, et al. Modulation of the response to Mycobacterium leprae and Pathogenesis of Leprosy. Frontiers in Microbiology. Volume 13. Frontiers Media S.A.; 2022.","DOI":"10.3389\/fmicb.2022.918009"},{"key":"9937_CR62","doi-asserted-by":"publisher","unstructured":"Mattos KA, Lara FA, Oliveira VGC, Rodrigues LS, D\u2019Avila H, Melo RCN et al. Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: a putative mechanism for host lipid acquisition and bacterial survival in phagosomes. Cell Microbiol [Internet]. 2011;13(2):259\u201373. https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/j.1462-5822.2010.01533.x","DOI":"10.1111\/j.1462-5822.2010.01533.x"},{"key":"9937_CR63","unstructured":"Job C, Chehl S, Hastings R. Foam\u2014the result of an Interaction between UnactivatedMacrophages and Dead Mycobacterium leprae? Volume 50. J. Lepr. New Orleans; 1983."},{"issue":"3","key":"9937_CR64","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1489\/1544-581X(2003)71<227:RSZILA>2.0.CO;2","volume":"71","author":"I Kaur","year":"2003","unstructured":"Kaur I, Indira D, Dogra S, Sharma VK, Das A, Kumar B. Relatively spared zones in Leprosy: a clinicopathological study of 500 patients. Int J Lepr Other Mycobact Dis. 2003;71(3):227.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"9937_CR65","doi-asserted-by":"crossref","unstructured":"Margarida S, Ferreira B. Clinical and laboratory characteristics in the retreatment of leprosy relapse Caracter\u00edsticas cl\u00ednico-laboratoriais no retratamento por recidiva em hansen\u00edase Eliane Ignotti II M\u00f4nica Antar Gamba III. 15, Rev Bras Epidemiol. 2012.","DOI":"10.1590\/S1415-790X2012000300011"},{"key":"9937_CR66","doi-asserted-by":"crossref","unstructured":"Cruz RCdaS, B\u00fchrer-S\u00e9kula S, Penna MLF, Penna GO, Talhari S. Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients. An Bras Dermatol [Internet]. 2017;92(6):761\u201373. http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962017000600761&lng=en&tlng=en","DOI":"10.1590\/abd1806-4841.20176724"},{"key":"9937_CR67","doi-asserted-by":"crossref","unstructured":"Ruth Butlin C, Pahan D, Kya A, Maug J, Withington S, Nicholls P et al. Outcome of 6 months MBMDT in MB patients in Bangladesh-preliminary results ******Advisor on Multiresistant Tb, National Tuberculosis Control Programme of Bangladesh the place where work was done: leprosy control project areas under Damien Foundation (14 districts) and the Leprosy Mission International Bangladesh (2 districts). 87. 2016.","DOI":"10.47276\/lr.87.2.171"},{"key":"9937_CR68","doi-asserted-by":"publisher","unstructured":"Amenu A, Saunderson P, Desta K, Byass P. The pattern of decline in bacillary index after 2 years of WHO recommended multiple drug therapy: the AMFES cohort. Lepr Rev [Internet]. 2000;71(3). http:\/\/www.gnresearch.org\/doi\/https:\/\/doi.org\/10.5935\/0305-7518.20000037","DOI":"10.5935\/0305-7518.20000037"},{"key":"9937_CR69","unstructured":"Saunderson PR. Uniform multidrug therapy for leprosy \u2013 Time for a rethink? Vol. 144, Indian Journal of Medical Research. Indian Council of Medical Research; 2016. pp. 499\u2013501."},{"issue":"12","key":"9937_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0000921","volume":"4","author":"MAB Trindade","year":"2010","unstructured":"Trindade MAB, Benard G, Ura S, Ghidella CC, Avelleira JCR, Vianna FR, et al. Granulomatous reactivation during the course of a leprosy infection: reaction or relapse. PLoS Negl Trop Dis. 2010;4(12):1\u20135.","journal-title":"PLoS Negl Trop Dis"},{"key":"9937_CR71","doi-asserted-by":"crossref","unstructured":"Maghanoy A, Mallari I, Balagon M, Saunderson P. Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines. Lepr Rev [Internet]. 2011;82(1):65\u20139. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21644473","DOI":"10.47276\/lr.82.1.65"},{"key":"9937_CR72","doi-asserted-by":"crossref","unstructured":"B\u00fchrer-S\u00e9kula S. PGL-I leprosy serology. Volume 41. Revista da Sociedade Brasileira de Medicina Tropical; 2008.","DOI":"10.1590\/S0037-86822008000700002"},{"key":"9937_CR73","doi-asserted-by":"publisher","unstructured":"Chin-a-Lien R, Faber W, Rens M, Leiker D, Naafs B, KLlaster P. Follow-up of multibacillary leprosy patients using a phenolic glycolipid-I-based ELISA. Do increasing ELISA-values after discontinuation of treatment indicate relapse? Lepr Rev [Internet]. 1992;63(1). http:\/\/www.gnresearch.comhttps:\/\/doi.org\/10.5935\/0305-7518.19920004","DOI":"10.5935\/0305-7518.19920004"},{"key":"9937_CR74","unstructured":"Cho SN, Cellona RV, Fajardo TT, Abalos RM, dela Cruz EC, Walsh GP et al. Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens. Int J Lepr Other Mycobact Dis [Internet]. 1991;59(1):25\u201331. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2030314"},{"issue":"1","key":"9937_CR75","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1128\/CDLI.8.1.138-142.2001","volume":"8","author":"SN Cho","year":"2001","unstructured":"Cho SN, Cellona RV, Villahermosa LG, Fajardo TT, Balagon MVF, Abalos RM, et al. Detection of phenolic glycolipid I of Mycobacterium leprae in Sera from Leprosy patients before and after start of Multidrug Therapy. Clin Diagn Lab Immunol. 2001;8(1):138\u201342.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"12","key":"9937_CR76","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/j.1365-3156.2007.01951.x","volume":"12","author":"EA Silva","year":"2007","unstructured":"Silva EA, Iyer A, Ura S, Lauris JR, Naafs B, Das PK, et al. Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions. Trop Med Int Health. 2007;12(12):1450\u20138.","journal-title":"Trop Med Int Health"},{"key":"9937_CR77","doi-asserted-by":"crossref","unstructured":"Richardus RA, van der Zwet K, van Hooij A, Wilson L, Oskam L, Faber R et al. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh. PLoS Negl Trop Dis. 2017;11(12).","DOI":"10.1371\/journal.pntd.0006083"},{"key":"9937_CR78","unstructured":"Stefani MMA, Martelli CMT, Morais-Neto OL, Martelli P, Costa MB, Lucia A et al. Assessment of Anti-PGL-I as a prognostic marker of Leprosy reaction\u2019. 66."},{"key":"9937_CR79","doi-asserted-by":"crossref","unstructured":"Murthy JMK, Dastur FD, Khadilkar SV, Kochar DK. In. Rabies, tetanus, leprosy, and malaria. 2014. pp. 1501\u201320.","DOI":"10.1016\/B978-0-7020-4088-7.00101-2"},{"key":"9937_CR80","unstructured":"Meeker HC, Schuller-Levis G, Fusco F, Giardina-Becket MA, Sersen E, Levis WR. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan. Int J Lepr Other Mycobact Dis [Internet]. 1990;58(3):503\u201311. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2205685"},{"issue":"8866","key":"9937_CR81","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/0140-6736(93)91816-5","volume":"342","author":"S Jamil","year":"1993","unstructured":"Jamil S, Keer JT, Dockrell HM, Stoker NG, Lucas SB, Chiang TJ, et al. Use of polymerase chain reaction to assess efficacy of leprosy chemotherapy. Lancet. 1993;342(8866):264\u20138.","journal-title":"Lancet"},{"key":"9937_CR82","doi-asserted-by":"crossref","unstructured":"Manta FSN, Barbieri RR, Moreira SJM, Santos PTS, Nery JAC, Duppre NC et al. Quantitative PCR for leprosy diagnosis and monitoring in household contacts: a follow-up study, 2011\u20132018. Sci Rep. 2019;9(1).","DOI":"10.1038\/s41598-019-52640-5"},{"key":"9937_CR83","doi-asserted-by":"crossref","unstructured":"Martinez AN, Talhari C, Moraes MO, Talhari S. PCR-Based techniques for Leprosy diagnosis: from the Laboratory to the clinic. PLoS Negl Trop Dis. 2014;8(4).","DOI":"10.1371\/journal.pntd.0002655"},{"key":"9937_CR84","doi-asserted-by":"crossref","unstructured":"Hatta M. Monitoring of the efficacy of multidrug therapy (MDT) by polymerase chain reaction (PCR) and, Mycobacterium leprae particle agglutination (MLPA) test in leprosy patients. Medical Journal of Indonesia [Internet]. 1997;208. http:\/\/mji.ui.ac.id\/journal\/index.php\/mji\/article\/view\/829","DOI":"10.13181\/mji.v6i4.829"},{"key":"9937_CR85","doi-asserted-by":"crossref","unstructured":"Santos AR, Balassiano V, Oliveira MLW, Pereira MA, da Santos S, Degrave PB et al. WM,. Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood of individuals, eight years after completion of anti-leprosy therapy. Mem Inst Oswaldo Cruz [Internet]. 2001;96(8):1123\u201333. http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0074-02762001000800017&lng=en&tlng=en","DOI":"10.1590\/S0074-02762001000800017"},{"key":"9937_CR86","doi-asserted-by":"crossref","unstructured":"Pinheiro MDS, de Oliveira NG, Santos DCM dos, Leite HM, Baptista IMFD, Fairley JK et al. Impacto da qPCR na avalia\u00e7\u00e3o diagn\u00f3stica de indiv\u00edduos com suspei\u00e7\u00e3o de hansen\u00edase. Research, Society and Development. 2023;12(3):e13312340549.","DOI":"10.33448\/rsd-v12i3.40549"},{"key":"9937_CR87","doi-asserted-by":"crossref","unstructured":"Matsuoka M. Drug resistance in leprosy. Jpn J Infect Dis [Internet]. 2010;63(1):1\u20137. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20093754","DOI":"10.7883\/yoken.63.1"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09937-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09937-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09937-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T04:02:15Z","timestamp":1727755335000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09937-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9937"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09937-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"14 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research followed the principles of the Declaration of Helsinki. Informed consent was waived and the research was approved by the Research Ethics Committee of the Federal University of Uberl\u00e2ndia (CAAE: 42878620.0.0000.5152) on 16\/04\/2021. The data were obtained from medical records, specific software, and SINAN, and were blinded for analysis. The informed consent waiver was also requested due to the difficulty of obtaining written consent from patients in a long-term retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1085"}}